An update on autonomic neuropathy affecting the gastrointestinal tract

Current Diabetes Reports

Volumn 6, Issue 6, 2006, Pages 417-423

  Phillips, Liza K ^b   Rayner, Christopher K ^b   Jones, Karen L ^b   Horowitz, Michael ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ALPHA GLUCOSIDASE INHIBITOR; ANTIEMETIC AGENT; ANTIOXIDANT; ATILMOTIN; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CISAPRIDE; CPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOMPERIDONE; ERYTHROMYCIN; GHRELIN; GLUCOSE; INSULIN; ITOPRIDE; KAPPA OPIATE RECEPTOR AGONIST; METOCLOPRAMIDE; MITEMCINAL; MOSAPRIDE; MOTILIN AGONIST; NEUROTROPHIN; ONDANSETRON; PRAMLINTIDE; PROKINETIC AGENT; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SILDENAFIL; SULPIRIDE; TEGASEROD; UNINDEXED DRUG;

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIARRHEA; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DRUG CHOICE; DRUG MECHANISM; DRUG PENETRATION; DRUG TOLERABILITY; ELECTROSTIMULATION THERAPY; FECES INCONTINENCE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRACT SCINTISCANNING; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTESTINAL DYSMOTILITY; NAUSEA; NONHUMAN; PANCREAS TRANSPLANTATION; PATHOGENESIS; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PREVALENCE; QT PROLONGATION; REVIEW; STOMACH EMPTYING; STOMACH PARESIS; STOMACH SURGERY;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD GLUCOSE; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; GASTRIC EMPTYING; GASTROINTESTINAL TRACT; HUMANS;

EID: 33845408592     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-006-0073-0     Document Type: Review

References (60)

1. Forster J, Damjanov I, Lin Z, et al.: Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005, 2:588-590.
2. Smout AJ: Oesophageal function. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:97-116.
3. Horowitz M, Dent J, Fraser R, et al.: Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci 1994, 39:S7-S13.
4. Horowitz M, Jones KL, Akkermans LMA, Samson M: Gastric function. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:117-176.
5. Horowitz M, Edelbroek M, Wishart JM, Straathof JW: Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993, 36:857-862.
6. Samson M, Verhagen M: Intestinal function. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:177-217.
7. Sun WS, Read N: Anorectal function. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:219-246.
8. Hammer J, Abell T, Cutts T, Talley NJ. Epidemiology of disordered gastrointestinal function and impact of chronic gastrointestinal symptoms on quality of life. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:1-27.
9. Bytzer PM, Talley NJ, Hammer J, et al.: Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,0000 adults. Arch Intern Med 2000, 161:1989-1996.
10. Enck P, Rathmann W, Spiekermann M, et al.: Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994, 32:637-641.
11. Low PA, Benrud-Lason LM, Sletten DM, et al.: Autonomic symptoms and diabetic neuropathy. A population-based study. Diabetes Care 2004, 27:2942-2947.
12. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
13. Young AA, Edwards GL: Effects of diabetes mellitus on gastrointestinal function in animal models. In Gastrointestinal Function in Diabetes Mellitus. Edited by Horowitz M, Samsom M. Chichester: John Wiley and Sons; 2004:29-95.
14. Ordog T, Takayama I, Cheung WK, et al.: Remodelling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000, 49:19731-19739.
15. Horvath VJ, Vittal H, Lorincz A, et al.: Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology 2006, 130:759-770.
16. Shotton HR, Lincoln J: Diabetes only affects nitric oxide synthase-containing myenteric neurons that do not contain heme oxygenase 2. Brain Res 2006, 1068:248-256.
17. Anitha M, Gondha C, Sutliff R, et al.: GDNF rescues hyperglycaemia-induced diabetic enteric neuropathy through activation of the P13/Akt pathway. J Clin Invest 2006, 116:344-356.
18. Yoshida MM, Schuffler MD, Sumi SM: There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology 1988, 94:907-914.
19. Gilbey SG, Guy RJ, Jones H, et al.: Diabetes and autonomic neuropathy: an immunological association? Diabet Med 1986, 3:241-245.
20. Granberg V, Ejskjaer N, Peakman M, Sunkvist C: Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care 2005, 28:1959-1964.
21. Jackson MW, Gordon TP, Waterman SA: Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 2004, 126:819-828.
22. He CL, Soffer EE, Ferris CD, et al.: Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121:427-434.
23. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al.: Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999, 16:488-495.
24. Rayner CK, Jones KL, Samsom M, Horowitz M: Relationships of upper gastrointestinal motor and sensory function with glycaemic control. Diabetes Care 2001, 24:371-381.
25. Fraser RJ, Horowitz M, Maddox AF, et al.: Hyperglycaemia slows gastric emptying in type 1 insulin-dependent diabetes mellitus. Diabetologia 1990, 30:675-680.
26. Schvarcz E, Palmer M, Aman J, et al.: Physiological hyperglycaemia slows gastric emptying in normal subjects and subjects with insulin-dependent diabetes mellitus. Gastroenterology 1997, 113:60-66.
27. Russo A, Stevens JE, Chen R, et al.: Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005, 90:4489-4495.
28. Maximilian B, Barnert J, Wienbeck M: Autonomic dysfunction and gastrointestinal tract. Clin Auton Res 1999, 9:75-81.
29. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985, 8:491-498.
30. Phillips WT, Schwartz JG, McMahan CA: Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 1992, 33:1496-1500.
31. Jones KL, Horowitz M, Carney BJ, et al.: Gastric emptying in early non insulin-dependent diabetes mellitus. J Nucl Med 1996, 37:1643-1648.
32. Rayner C, Horowitz M: New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol 2005, 2:454-462.
33. Jones KL, Russo A, Stevens JE, et al.: Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001, 24:1264-1269.
34. Horowitz M, Harding PE, Chatterton BE, et al.: Acute and chronic effect of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985, 30:1-9.
35. Farup CE, Leidy NY, Murray M, et al.: Effect of damperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 1998, 21:1699-1706.
36. Abell TL, Bernstein RK, Cutts T, et al.: Treatment of gastroparesis: a multidisciplinary clinical review. The American Motility Task Force on Gastroparesis. Neurogastroenterol Motil 2006, 18:263-283.
37. Jones KL, Berry M, Kong MF, et al.: Hyperglycaemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999, 22:339-344.
38. Janssens J, Peeters TL, Vantrappen G, et al.: Erythromycin improves delayed gastric emptying in diabetic gastroparesis. N Engl J Med 1990, 332:1028-1031.
39. Maganti K, Onyemere K, Jones MP: Oral erythromycin and symptomatic relief of gastroparesis: a systemic review. Am J Gastroenterol 2003, 98:259-263.
40. McHugh S, Lico S, Diamant NE: Cisapride vs metoclopramide. An acute study in diabetic gastroparesis. Dig Dis Sd 1992, 37:997-1001.
41. Melga P, Mansi C, Ciuchi E, et al.: Chronic administration of levosulpiride and glycaemic control in IDDM patients with gastroparesis. Diabetes Care 1997, 20:55-58.
42. Asawaka H, Hayashi I, Fukui T, Tokunga K: Effects of mosapride on glycaemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res Clin Pract 2003, 61:175-182.
43. Murray CD, Martin NM, Patterson M, et al.: Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005, 54:1693-1698.
44. Park MI, Ferber M, Camilleri K, et al.: Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006, 18:28-36.
45. McCallum RW, Rogel R, Fang JC, et al.: Mitemacil fumarate (GM-611) provided symptomatic relief of diabetic gastroparesis, especially in type 1 diabetics: results of a 12-week, multi-centre, double-blind, placebo controlled, randomized phase 2b study. Gastroenterology 2005, 128:A467.
46. Dishy V, Cohen Pour M, Feldman L, et al.: The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis. Clin Pharm Ther 2004, 76:281-286.
47. Stevens JE, Russo A, Delaney CA, et al.: Acute effects of C-peptide on gastric emptying in longstanding type 1 diabetes. Clin Auton Res 2006, 16:55-57.
48. Gaber AO, Oxley D, Karas J, et al.: Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis 1991, 9:437-443.
49. Lacy BE, Zayat EN, Crowell MD, Schuster MM: Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002, 97:1548-1552.
50. Lacy BE, Weiser K: Gastric motility, gastroparesis, and gastric stimulation. Surg Clin North Am 2005, 85:967-987.
51. Forster J, Sarosiek I, Delcore R, et al.: Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001, 182:676-681.
52. Forster J, Sarosiek I, Lin Z, et al.: Further experience with gastric stimulation to treat refractory gastroparesis. Am J Surg 2003, 186:690-695.
53. Abell T, McCallum R, Hocking M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-428.
54. Lin Z, Sarosiek I, Forster J, McCallum RW: Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006, 18:18-27.
55. Abell T, Al-Juburi A, Bashed H, Miroch A: 13 years, 214 patients and over 5000 patient months: a long term report on gastric electric stimulation. Gastroenterology 2005, 50:1328-1334.
56. Lin Z, Forster J, Sarosiek I, McCallum RW: Treatment of diabetic gastroparesis by high-frequency nerve stimulation. Diabetes Care 2004, 27:1071-1076.
57. Horowitz M, Jones KL, Rayner CK, Read NW: "Gastric" hypoglycaemia - an important concept in diabetes management. Neurogastroenterol Motil 2006, 18:405-407.
58. Gallwitz B: Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus. Treat Endocrinol 2005, 4:361-370.
59. Meier JJ, Kemmenies G, Holst JJ, et al.: Erythromycin antagonises the deceleration of gastric emptying by glucagon-like-peptide-1 and unmasks its insulinotropic effect in healthy subjects. Diabetes 2005, 54:2212-2218.
60. Battle WM, Snape WJ Jr, Alavi A, et al.: Colonic dysfunction in diabetes mellitus. Gastroenterology 1980, 79:1217-1221.